U.S Mammography and Breast Imaging Market Outlook Report 2022: Mammography Department Budgets Anticipated to Grow at an Estimated 9.7% Each Year from 2023 Through 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2022 U.S Mammography and Breast Imaging Market Outlook Report” report has been added to ResearchAndMarkets.com’s offering.

Mammography departments are anticipating that their current budgets will grow by an estimated 9.7% per year from 2023 through 2025, according to the 2022 Mammography and Breast Imaging Market Outlook Report.

For the first time in over a decade, the analyst has relaunched coverage of mammography and breast imaging in its popular market outlook series. According to the 2022 survey of mammography departments, the top five priorities of mammography departments are as follows:

Improve patient satisfaction with their mammography experience.

Obtain/maintain mammography department accreditation.

Improve staff satisfaction and morale.

Better cancer detection for dense breast screening.

Satisfy the needs of referring physicians.

As indicated by respondents, the impact of the COVID-19 pandemic on mammography departments peaked in 2020 and is now at the lowest level since that time. The peak impact occurred in 2020 with 87% of departments experiencing a medium or high impact from the pandemic with an average rating of 8.6/10, with 10 being the highest impact. At the time of the survey in the fall of 2022, 21% of sites continued to experience a medium or high impact with an average rating of 4.1/10.

In the 2022 survey, an estimated 91% of 400+ bed hospitals, 64% of nonhospitals, 53% of 200-399 bed hospitals, and 14% of < 200-bed hospitals performed over 6,000 annual mammography procedures per site. In 2022 overall, 25% of mammography procedures were performed for diagnostic purposes and 75% for screening purchases. Mammography-related biopsies are collected at 75% of facilities.

According to the 2022 survey, Hologic has the largest mammography installed base share with 69% followed by GE HealthCare with 20%, Siemens Healthineers with 8%, Fujifilm Healthcare Americas with 1%, and Philips with < 1%.

After a 17% decline in 2022, mammography department budgets are anticipated to grow an estimated 9.7% each year from 2023 through 2025, for sites with a nonzero budget. Regarding mammography system purchase plans, 36% of sites are “Yes, Planning” or “Maybe Planning” to purchase systems over the next three years.

Despite the popularity of the topic, 63% of mammography sites are not currently using artificial intelligence (AI). For sites that are using AI, the most common uses of AI technology in mammography practices are for clinical support to radiologists in diagnostic interpretations, first-pass screening for lesions, to improve image quality output and workflow optimization.

In 2022, on average mammography sites were open 8.9 hours per weekday and 1.9 hours per weekend.

The 2022 Mammography and Breast Imaging Market Outlook Report explores market trends in U.S. hospitals and imaging centers, including procedure volume, manufacture-installed base features and share, the use of OEM vs. third-party service providers, purchase plans, brand loyalty, biopsy modalities and procedures, additional breast care modalities, trending topics in breast imaging and site operations characteristics.

The Mammography and Breast Imaging Market Outlook Report was published in December 2022 and is based on responses from 223 radiology/departmental administrators and clinicians who participated in the nationwide survey in September-November 2022.

Key Topics Covered:

Background and Objectives

Methodology

Mammography Market Outlook Executive Summary

Mammography Priorities & Outlook

Trends in Mammography Procedure Volume and Mix

Biopsy Modalities and Procedures

Installed Base of Mammography Scanners

Mammography Purchase Plans

Additional Breast Care Modalities

Trending Topics in Breast Imaging

Demographics & Site Operations Characteristics

A selection of companies mentioned in this report includes

Fujifilm

GE HealthCare

Hologic

Philips

Siemens Healthineers

The 2022 Mammography and Breast Imaging Market Outlook Report summarizes the results of the analyst’s Medical Information Division’s 2022 survey of U.S. hospitals and independent imaging centers that perform mammography procedures using mammography scanners and provides a summary of the mammography and breast imaging medical imaging market. The report provides detailed information about the priorities and outlook of departments with mammography scanners, information about procedure volumes and the mix of procedures performed using mammography systems.

The report also covers installed base information and future purchase plans, including information about which manufacturers are present and being considered for purchase over the next few years. The report includes detailed information about the departments in the hospital where the equipment is currently located including in the main radiology department, mammography, women’s health, breast care and outpatient departments.

The report includes a wide variety of charts and graphs that breakout the above information along a number of dimensions including department type and hospital size. The key features and findings of these charts are highlighted in the report.

Respondents participated in a hosted online survey from September 07 to November 18, 2022.

This report is ideal for anyone interested in learning more about how advancements in mammography and breast imaging are impacting the medical diagnostic imaging market.

It is a great resource for:

Marketing Managers

Product Managers

Marketing Directors

Sales Managers

Analysts

That work in diagnostic imaging equipment manufacturing, hospital and healthcare systems, consulting, investment and finance industries. This report is a great way to get a quick overview of recent developments and help to plan for what lies ahead.

For more information about this report visit https://www.researchandmarkets.com/r/py3kim

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.